Evidence map›Paper›PMID 28220044›Full record

ArticleMolecular psychiatry2017

Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice.

A Busquets-Garcia, E Soria-Gómez, B Redon, Y Mackenbach, M Vallée, F Chaouloff, M Varilh, G Ferreira, P-V Piazza, G Marsicano

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Metabolic activation of flunitrazepam via nitroreduction mediated by aldo-keto reductase 1C3.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. CB1 Cannabinoid Receptor Signaling and Biased Signaling.Molecules (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Review of the Endocannabinoid System.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

A Busquets-GarciaINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
E Soria-GómezINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
B RedonINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Y MackenbachINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
M ValléeINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
F ChaouloffINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
M VarilhINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
G FerreiraUniversity of Bordeaux, Bordeaux, France.
P-V PiazzaINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
G MarsicanoINSERM, U1215 NeuroCentre Magendie, Bordeaux, France.
Neurocentre Magendie · FRUniversité de Bordeaux · FRInserm · FRNutriNeuro · FR

Funding

European Research Council 260515
6 · The paper itself

Abstract

Cannabis-induced acute psychotic-like states (CIAPS) represent a growing health issue, but their underlying neurobiological mechanisms are poorly understood. The use of antipsychotics and benzodiazepines against CIAPS is limited by side effects and/or by their ability to tackle only certain aspects of psychosis. Thus, safer wide-spectrum treatments are currently needed. Although the blockade of cannabinoid type-1 receptor (CB1) had been suggested as a therapeutical means against CIAPS, the use of orthosteric CB1 receptor full antagonists is strongly limited by undesired side effects and low efficacy. The neurosteroid pregnenolone has been recently shown to act as a potent endogenous allosteric signal-specific inhibitor of CB1 receptors. Thus, we tested in mice the potential therapeutic use of pregnenolone against acute psychotic-like effects of Δ

Indexed as

AnimalsBrainCannabinoid Receptor AntagonistsCannabinoidsCannabisDronabinolMaleMental DisordersMiceMice, Inbred C57BLPregnenolonePsychoses, Substance-InducedReceptor, Cannabinoid, CB1Cannabinoid Receptor AntagonistsCannabinoidsDronabinolPregnenoloneReceptor, Cannabinoid, CB1

Identifiers

PMID28220044
PMCPMC5447368
OpenAlexW2591486770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.